Vanguard Group Inc Vericel Corp Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Vericel Corp stock. As of the latest transaction made, Vanguard Group Inc holds 3,485,532 shares of VCEL stock, worth $137 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,485,532
Previous 3,483,896
0.05%
Holding current value
$137 Million
Previous $147 Million
30.03%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VCEL
# of Institutions
290Shares Held
49.6MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$318 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$128 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$94.8 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$88.2 Million0.02% of portfolio
-
Conestoga Capital Advisors, LLC2.06MShares$81.3 Million1.39% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.86B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...